Untitled case
Active- Docket:
- 25-1210
Patents:7713947
A case filed in the Court of Appeals for the Federal Circuit, docket number 25-1210, which is currently active and listed as critical.
7713947
5 known cases. View patent page →
- Cases
- 5
- Active
- 1
- 4 closed
- Filed
- 2022
- Top venue
- D Del
- 4 cases
Merck KGaA et al. v. Hopewell Pharma Ventures, Inc. et al.
stayed- Docket:
- 1:22-cv-01365-GBW-CJB
- Court:
- D. Del.
- Filed:
- 2022-10-17
π Merck KGaAπ Merck Serono SAπ Ares Trading SAΔ Hopewell Pharma Ventures, Inc.Δ Aurobindo Pharma USA, Inc.Δ Aurobindo Pharma Ltd.Δ Apotex Inc.Δ Apotex Corp.
Original complaint asserted '919; plaintiffs ceased asserting the '919 patent against all defendants. The consolidated case was later globally stayed pending IPR appeals on the '947 and '903 patents.
Merck KGaA et al. v. Accord Healthcare, Inc.
stayed- Docket:
- 1:22-cv-00974-GBW
- Court:
- D. Del.
- Filed:
- 2022-07-25
First Amended Complaint (ANDA No. 216813) asserted the '947, '903, and '919 patents. The case was stayed within the same global stay; there was no separate '919 outcome.
Merck KGaA et al. v. Aurobindo Pharma USA, Inc. et al.
consolidated- Docket:
- 1:23-cv-00039-GBW-CJB
- Court:
- D. Del.
Consolidated into 22-1365. The '919 patent was asserted in the original complaint but dropped; the consolidated case involved the '947 and '903 patents.
Merck KGaA et al. v. Apotex Inc. et al.
consolidated- Docket:
- 1:23-cv-00655-GBW-CJB
- Court:
- D. Del.
Consolidated into 22-1365 (except trial). The '919 patent was asserted in the original complaint but dropped; Apotex's ANDA was approved Nov. 24, 2025. The consolidated case involved the '947 and '903 patents.